Cargando…
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.
Meta-analysis of the published results from 54 randomised controlled trials of adjuvant chemotherapy in head and neck cancer suggests that chemotherapy might increase absolute survival by 6.5% (95% confidence interval 3.1-9.9%). The odds ratio in favour of chemotherapy is 1.37 (95% confidence interv...
Autor principal: | Munro, A. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033467/ https://www.ncbi.nlm.nih.gov/pubmed/7819055 |
Ejemplares similares
-
Adjuvant chemotherapy in head and neck cancer.
por: Stell, P. M., et al.
Publicado: (1990) -
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation – a randomised trial
por: Patil, Vijay, et al.
Publicado: (2023) -
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer
por: Tsukuda, M, et al.
Publicado: (2005) -
Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015) -
Meta-analysis of chemotherapy in head and neck cancer: reply to the letter from JP Pignon et al
por: Munro, AJ
Publicado: (1995)